Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study
AMA-IgG emerges as a promising biomarker of disease activity in cSLE, and its increase is in alignment with elevated IFNα2 expression.
Authors
- Marjan A. Versnel (ORCID: https://orcid.org/0000-0003-0245-5386)
- Marina Barguil Macêdo (ORCID: https://orcid.org/0000-0002-8927-5566)
- Sylvia Kamphuis (ORCID: https://orcid.org/0000-0002-1964-352X)
- M. J. Wahadat (ORCID: https://orcid.org/0000-0003-3961-1274)
- Christian Lood (ORCID: https://orcid.org/0000-0002-6171-1952)
- Albin Björk
Institutions
- Karolinska University Hospital (SE)
- University of Washington (US)
- Erasmus MC (NL)
- Karolinska Institutet (SE)
- Erasmus MC - Sophia Children’s Hospital (NL)
- Center for Rheumatology (US)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1093/rheumatology/keaf275
- Citations
- 1
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.67